基本信息
views: 276
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Morgan runs a translational research laboratory focused on identifying biomarkers associated with treatment response, primarily through molecular profiling of tumor cells circulating in the blood and bone marrow of men with prostate cancer. The goal of this work is to be able to use a “liquid biopsy” to inform decisions in the same way that tissue-based biopsies currently do. These efforts also seek to shed light on how tumors learn to evade certain treatments and how these resistance mechanisms can be targeted. Dr. Morgan also directs a number of clinical trials, primarily focused on understanding how cancer biomarkers can be utilized in order to provide more individualized management approaches. His research has received funding from the National Cancer Institute (NCI), the Department of Defense, the Prostate Cancer Foundation, the Taubman Institute, and the National Comprehensive Cancer Network, among others.
Research Interests
Papers共 534 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2024)
NEW ENGLAND JOURNAL OF MEDICINEno. 5 (2024): 482-484
Urologic Oncology: Seminars and Original Investigationsno. 7 (2024): 220.e1-220.e8
Journal of the National Comprehensive Cancer Network : JNCCNno. 3 (2024): 140-150
Nature communicationsno. 1 (2024)
Todd M. Morgan, Yi Ren,Siyi Tang, Wouter Zwerink,Emmalyn Chen,Akinori Mitani,Huei-Chung Huang,Jeffry P. Simko,Sandy DeVries,William U. Shipley,Alan Pollack, David Bowes,
The Journal of urology/The journal of urologyno. 4 (2024): 509-517
Société Internationale d’Urologie Journalno. 3 (2024): 202-213
JOURNAL OF UROLOGYno. 4 (2024): 518-525
Clinical Cancer Researchno. 10_Supplement (2024)
Load More
Author Statistics
#Papers: 530
#Citation: 12121
H-Index: 59
G-Index: 100
Sociability: 8
Diversity: 3
Activity: 417
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn